About the Conference
The Trans-Pacific Health Sciences Dialogue is a meeting for C-level biopharmaceutical industry executives and business development executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America.
This is a must-attend meeting for executives who have, or want to develop, a Trans-Pacific strategy. The event has developed a well-earned reputation as the best place for biopharma companies seeking to forge Trans-Pacific ventures to start exploring their options. Attendees come away with a broad overview and insights they simply will not get in other meetings.
Take a look at some photos from the 2014 Trans-Pacific Health Sciences Dialogue!
In 2015, the Trans-Pacific Health Sciences Dialogue will be held at:
Joseph B. Martin Conference Center
at Harvard Medical School
77 Avenue Louis Pasteur
Boston, MA 02115
Who Should Attend
The Trans-Pacific Health Sciences Dialogue is an event for senior biopharmaceutical executives, KOLs, select industry advisors and members of the financial community with a strategic interest in Trans-Pacific collaboration or investment.
Industry News from FiercePharmaAsia
- Stormy Australia hearings on transfer pricing by drug firms invoke Sergeant Schultz
Multinational drug firms in Australia faced a string of barbs in hearings held by a Senate panel into transfer pricing that included a reference to a fictitious German World War II prison camp guard.
Industry News from PharmAsia
- INTERVIEW: Turkish R&D Industry Sees Challenges Weighing On GrowthIn an exclusive interview with PharmAsia News, Dr. Umit Dereli, acting secretary-general of the Research Based Pharmaceutical Companies (AIFD) association in Turkey, assesses the market’s performance in the first quarter, pointing to a generally strong performance.<img src="http://feeds.feedburner.com/~r/_PharmAsiaNews/~4/OoOugvBkYXU" height="1" width="1" alt="" />